|1.||Voit, Thomas: 1 article (09/2015)|
|2.||Chandler, David: 1 article (09/2015)|
|3.||Chamova, Teodora: 1 article (09/2015)|
|4.||Bahlo, Melanie: 1 article (09/2015)|
|5.||Angelova, Lyudmila: 1 article (09/2015)|
|6.||Guergueltcheva, Velina: 1 article (09/2015)|
|7.||Krause, Sabine: 1 article (09/2015)|
|8.||Tournev, Ivailo: 1 article (09/2015)|
|9.||Cirak, Sebahattin: 1 article (09/2015)|
|10.||Pogoryelova, Oksana: 1 article (09/2015)|
08/01/2011 - "At 24 h after administration of NeutrAvidin, labeled with either a far-red fluorophore or (111)In, there was a significant azido-labeled N-acetyl-mannosamine-dependent increase in tumor-to-tissue contrast, which was detected using optical imaging or single-photon-emission computed tomography (SPECT), respectively. "
10/20/2000 - "The expression of alpha2-8 N-propionylated polysialic acid and the lysis of tumor cells by antibody-dependent cytotoxicity depended on the time and dose of incorporation of N-propionylated mannosamine. "
03/21/2006 - "To identify the proper precursor for this application, N-propionyl, N-butanoyl, N-isobutanoyl, and N-phenylacetyl derivatives of d-mannosamine were synthesized, and their efficiency as biosynthetic precursors in modifying sialic acid and inducing expression of modified forms of GM3 antigen on tumor cells was investigated. "
02/01/1972 - "Effects of D-glucosamine, D-mannosamine, and 2-deoxy-D-glucose on the ultrastructure of ascites tumor cells in vitro."
|2.||T-Cell Leukemia (Leukemia, T Cell)
07/01/1982 - "D-Mannosamine is toxic to human malignant T-lymphoid cell lines derived from patients with T-cell leukemia. "
09/01/1985 - "Cytotoxic effects of mannosamine and free fatty acids on human malignant T-lymphoid cell lines derived from patients with T-cell leukemia were investigated. "
09/01/1985 - "Antitumor activity of D-mannosamine in vitro: cytotoxic effect produced by mannosamine in combination with free fatty acids on human leukemia T-cell lines."
|3.||Muscular Diseases (Myopathy)
09/01/2015 - "GNE myopathy is an autosomal-recessive disorder caused by mutations in the GNE gene, encoding the key enzyme in the sialic acid biosynthetic pathway, UDP-N-acetylglucosamine 2-epimerase/N-acetyl mannosamine kinase. "
01/01/2012 - "Mutations in the key enzyme of sialic acid biosynthesis, UDP-N-acetylglucosamine 2-epimerase/N-acetyl-mannosamine kinase, result in distal myopathy with rimmed vacuoles (DMRV)/hereditary inclusion body myopathy (HIBM) in humans. "
|5.||Distal Myopathies (Distal Muscular Dystrophy)
|1.||N-Acetylneuraminic Acid (Sialic Acid)
|2.||Uridine Diphosphate (UDP)
|6.||Tretinoin (Retinoic Acid)